No Cover Image

Journal article 152 views 11 downloads

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials / Subodh Verma, Darren K. McGuire, Steve Bain, Deepak L. Bhatt, Lawrence A. Leiter, C. David Mazer, Tea Monk Fries, Richard E. Pratley, Søren Rasmussen, Hrvoje Vrazic, Bernard Zinman, John B. Buse

Diabetes, Obesity and Metabolism, Volume: 22, Issue: 12

Swansea University Author: Steve Bain

Check full text

DOI (Published version): 10.1111/dom.14160

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54840
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-07-31T09:10:42Z
last_indexed 2021-01-07T04:18:39Z
id cronfa54840
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-01-06T17:35:57.9663825</datestamp><bib-version>v2</bib-version><id>54840</id><entry>2020-07-31</entry><title>Effects of glucagon&#x2010;like peptide&#x2010;1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-07-31</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>22</volume><journalNumber>12</journalNumber><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1462-8902</issnPrint><issnElectronic>1463-1326</issnElectronic><keywords/><publishedDay>0</publishedDay><publishedMonth>0</publishedMonth><publishedYear>0</publishedYear><publishedDate>0001-01-01</publishedDate><doi>10.1111/dom.14160</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-01-06T17:35:57.9663825</lastEdited><Created>2020-07-31T10:06:01.4559464</Created><path><level id="1"/><level id="2"/></path><authors><author><firstname>Subodh</firstname><surname>Verma</surname><order>1</order></author><author><firstname>Darren K.</firstname><surname>McGuire</surname><order>2</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>3</order></author><author><firstname>Deepak L.</firstname><surname>Bhatt</surname><order>4</order></author><author><firstname>Lawrence A.</firstname><surname>Leiter</surname><order>5</order></author><author><firstname>C. David</firstname><surname>Mazer</surname><order>6</order></author><author><firstname>Tea Monk</firstname><surname>Fries</surname><order>7</order></author><author><firstname>Richard E.</firstname><surname>Pratley</surname><order>8</order></author><author><firstname>S&#xF8;ren</firstname><surname>Rasmussen</surname><order>9</order></author><author><firstname>Hrvoje</firstname><surname>Vrazic</surname><order>10</order></author><author><firstname>Bernard</firstname><surname>Zinman</surname><order>11</order></author><author><firstname>John B.</firstname><surname>Buse</surname><order>12</order></author></authors><documents><document><filename>54840__17819__09db95ab60a944efbb2786c7b99ad972.pdf</filename><originalFilename>Verma2020.pdf</originalFilename><uploaded>2020-07-31T10:09:35.5047941</uploaded><type>Output</type><contentLength>663691</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2021-08-03T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>English</language></document></documents><OutputDurs/></rfc1807>
spelling 2021-01-06T17:35:57.9663825 v2 54840 2020-07-31 Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-07-31 BMS Journal Article Diabetes, Obesity and Metabolism 22 12 Wiley 1462-8902 1463-1326 0 0 0 0001-01-01 10.1111/dom.14160 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2021-01-06T17:35:57.9663825 2020-07-31T10:06:01.4559464 Subodh Verma 1 Darren K. McGuire 2 Steve Bain 0000-0001-8519-4964 3 Deepak L. Bhatt 4 Lawrence A. Leiter 5 C. David Mazer 6 Tea Monk Fries 7 Richard E. Pratley 8 Søren Rasmussen 9 Hrvoje Vrazic 10 Bernard Zinman 11 John B. Buse 12 54840__17819__09db95ab60a944efbb2786c7b99ad972.pdf Verma2020.pdf 2020-07-31T10:09:35.5047941 Output 663691 application/pdf Accepted Manuscript true 2021-08-03T00:00:00.0000000 true English
title Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
spellingShingle Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
Steve, Bain
title_short Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
title_full Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
title_fullStr Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
title_full_unstemmed Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
title_sort Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve, Bain
author Steve, Bain
author2 Subodh Verma
Darren K. McGuire
Steve Bain
Deepak L. Bhatt
Lawrence A. Leiter
C. David Mazer
Tea Monk Fries
Richard E. Pratley
Søren Rasmussen
Hrvoje Vrazic
Bernard Zinman
John B. Buse
format Journal article
container_title Diabetes, Obesity and Metabolism
container_volume 22
container_issue 12
institution Swansea University
issn 1462-8902
1463-1326
doi_str_mv 10.1111/dom.14160
publisher Wiley
document_store_str 1
active_str 0
published_date 0001-01-01T04:13:34Z
_version_ 1718368615153008640
score 10.844268